Home » Topics » Regulatory » Patents

Patents
RSS

Yamanouchi reports vasopressin V1 receptor antagonists

May 31, 1996

Thrombin inhibitors claimed by Boehringer Mannheim

May 31, 1996

Taisho researchers reveal cGMP-dependent phosphodiesterase (PDE V) inhibitors

May 31, 1996

Endothelin antagonists revealed by Fujisawa

May 31, 1996

Sanofi Winthrop research reveals elastase inhibitors

May 31, 1996

Nikken Chemicals reports antiallergic/antiinflammatory N-hydroxyureas

May 31, 1996

Hyaluronic acid and derivatives described by Hyal

May 31, 1996

Neurotrophic polypeptides disclosed by Children's Medical Center

May 31, 1996

Gedeon Richter discloses antiamnestic ethers

May 31, 1996

Pentynoic acid derivatives revealed by ABS and the University College Dublin

May 31, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.